Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis

J Allergy Clin Immunol. 2007 Jun;119(6):1550-1. doi: 10.1016/j.jaci.2007.03.032. Epub 2007 May 3.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Anaphylaxis / drug therapy*
  • Anaphylaxis / immunology
  • Anaphylaxis / pathology
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Humans
  • Male
  • Mastocytosis, Systemic / drug therapy*
  • Mastocytosis, Systemic / immunology
  • Mastocytosis, Systemic / pathology
  • Middle Aged
  • Omalizumab
  • Receptors, IgE / antagonists & inhibitors
  • Urticaria Pigmentosa / drug therapy
  • Urticaria Pigmentosa / immunology
  • Urticaria Pigmentosa / pathology

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Receptors, IgE
  • Omalizumab